Angiotensin-converting enzyme 2 (ACE2) levels in relation to risk factors for COVID-19 in two large cohorts of patients with atrial fibrillation

AIMS: The global COVID-19 pandemic is caused by the SARS-CoV-2 virus entering human cells using angiotensin-converting enzyme 2 (ACE2) as a cell surface receptor. ACE2 is shed to the circulation, and a higher plasma level of soluble ACE2 (sACE2) might reflect a higher cellular expression of ACE2. Th...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Eur Heart J
Päätekijät: Wallentin, Lars, Lindbäck, Johan, Eriksson, Niclas, Hijazi, Ziad, Eikelboom, John W, Ezekowitz, Michael D, Granger, Christopher B, Lopes, Renato D, Yusuf, Salim, Oldgren, Jonas, Siegbahn, Agneta
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Oxford University Press 2020
Aiheet:
Clinical Research
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7543499/
https://ncbi.nlm.nih.gov/pubmed/32984892
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/eurheartj/ehaa697
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia